posts category

Press Room

The unique genetic diversity that is prevalent in South, North, and East Asia provides a valuable source for clinical insights that will be able to enhance the understanding of disease biology. In order to help accelerate population specific precision medicine, Macrogen got involved with Genome Asia 100K in 2016, and …

Continue reading

  What does it mean to map the human genome? Humans may be 99.9 per cent similar to one another, yet the miniscule remaining percentage spells all the difference – making one drug effective for one patient and life-threatening for another. Having a map of one’s genome means …

Continue reading

– Establishment of Genome Sequencing Industry’s First Branch in Spain, Strengthening Localization Service in Southern Europe and MENA SEOUL, South Korea– Macrogen inc. (CEO Hyon Yong Chong, www.macrogen.com) (KOSDAQ:038290), a precision medicine biotechnology company, announced on Sep 4 that it will begin providing localization service …

Continue reading

From an international collaborative study, researchers from Harvard Medical School and Macrogen, a Korean biotech company, have discovered that the body’s immune system initially detects the presence of anthrax spores by recognizing RNA molecules that coat the spores’ surface. But this prompts an unfavorable immune response that hinders the …

Continue reading

Macrogen Inc. (CEO Hyun-yong Jeong, www.macrogen.com), which is a precision medicine biotechnology company, announced on March 30, 2017 that it has acquired accreditation as an international authorized test agency for its forensic genetic relationship test from the Korea Laboratory Accreditation Scheme (KOLAS), which is a Korean accreditation …

Continue reading